enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Apotex - Wikipedia

   en.wikipedia.org/wiki/Apotex

   Apotex Inc. Apotex Inc. is a Canadian pharmaceutical corporation. [ 4] Founded in 1974 by Barry Sherman, the company is the largest producer of generic drugs in Canada, with annual sales exceeding CA$ 2.5 billion. [ 5] By 2023, Apotex employed close to 8,000 people as Canada's largest drug manufacturer, with over 300 products selling in over ...

3. Barry Sherman - Wikipedia

   en.wikipedia.org/wiki/Barry_Sherman

   Children. 4. Family. Louis Lloyd Winter (uncle) Bernard Charles " Barry " Sherman, CM [ 4] (February 25, 1942 – December 13, 2017) was a Canadian businessman and philanthropist who was chairman and CEO of Apotex Inc. With an estimated net worth of US$3.2 billion at the time of his death, according to Forbes, Sherman was the 12th-wealthiest ...

4. Clopidogrel - Wikipedia

   en.wikipedia.org/wiki/Clopidogrel

   In 2006, generic clopidogrel was briefly marketed by Apotex, a Canadian generic pharmaceutical company before a court order halted further production until resolution of a patent infringement case brought by Bristol-Myers Squibb. [49] The court ruled that Bristol-Myers Squibb's patent was valid and provided protection until November 2011. [50]

5. This Big Pharma Pair Parts Ways - AOL

   www.aol.com/2012/10/04/this-big-pharma-pair...

   Most notably, there was the 2006 at-risk launch of generic Plavix by Apotex. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways ...

6. Why Generic Drugs Aren’t Getting Cheaper for You - AOL

   www.aol.com/why-generic-drugs-aren-t-130107243.html

   The Wall Street Journal reported that companies like CVS Health and Cigna priced some specialty generic drugs “at least 24 times higher on average than roughly what the medicines ...

7. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   The result is that apixaban generics will most likely not be available in the United States until at least 2026, but possibly 2031. [ 16 ] In July 2022, the Canadian generic drug company, Apotex Inc. , obtained approval for marketing of apixaban.